- $14.09m
- -$3.46m
Annual balance sheet for BioVie, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4.51 | 18.6 | 33.9 | 23.8 | 17.5 |
Net Total Receivables | — | — | — | — | 2.1 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4.61 | 18.8 | 34 | 24 | 20.7 |
Net Property, Plant And Equipment | — | 0.118 | 0.081 | 0.407 | 0.34 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 6.05 | 20.1 | 35.1 | 25.2 | 21.6 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.996 | 4.17 | 14.5 | 9.35 | 2.27 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.996 | 16.4 | 19.8 | 9.7 | 2.55 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 5.05 | 3.67 | 15.3 | 15.5 | 19 |
Total Liabilities & Shareholders' Equity | 6.05 | 20.1 | 35.1 | 25.2 | 21.6 |
Total Common Shares Outstanding |